Metabolic syndrome and diabetes mellitus in COPD

Claire E. Wells, Emma H. Baker

Source: Eur Respir Monogr 2013; 59: 117-134

Journal Issue: COPD and Comorbidity

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Claire E. Wells, Emma H. Baker. Metabolic syndrome and diabetes mellitus in COPD. Eur Respir Monogr 2013; 59: 117-134

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The association between metabolic syndrome, obesity and asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008
Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
The role of inflammation in diabetes and obesity Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity) Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
Malnutrition and obesity in COPD Source: Eur Respir Mon 2013; 59: 80-92 Year: 2013
Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Diabetes and metabolic aspects of OSA Source: Eur Respir Mon 2010; 50: 189-215 Year: 2010
Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Evaluation of association between OSA and metabolic syndrome, insulin resistance and Hs-CRP Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Metabolic aspects of obstructive sleep apnoea syndrome Source: Eur Respir Rev 2009; 18: 113-124 Year: 2009
Adipose tissue in obesity and obstructive sleep apnoea Source: Eur Respir J 2012; 39: 746-767 Year: 2012
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Obesity and pulmonary hypertension Source: Eur Respir Mon 2012; 57: 194-207 Year: 2012
When obesity is not enough Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea Year: 2017
Covid-19 and obesity Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006
Insulin resistance modifies the association between obesity and current asthma in adults Source: Eur Respir J 2016; 48: 403-410 Year: 2016